openPR Logo
Press release

At 4% of CAGR, Colorectal Cancer Market is Growing with $22,953.8 Million in 2027 - Clinical Genomics Technologies, EDP Biotech Corporation, Volitionrx Limited, Abbott Laboratories, Amgen, F. Hoffmann-La Roche

11-19-2019 01:01 PM CET | Science & Education

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

Colorectal cancer is one of the commonly found and lethal cancers which is developed in an individual with the combined influence of genetic and environmental factors. Additionally, according to the World Health Organization (WHO), colorectal cancer was the third most prevalent form of cancers, with approximately 1.80 million cases around the world in 2018, excluding skin cancer. The rates of colorectal cancer mortality and incidence vary across the globe as per the reports by WHO’s cancer database GLOBOCAN. The GLOBOCAN reports approximately 861,000 deaths in 2018 due to colorectal cancer.

Generic drugs are alternatives of branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers does not invest in the development and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Generic drugs are important in oncology due to the fact that some of the anticancer drugs are only offered as generics. Patients are likely seen to abandon branded prescriptions which are majorly associated with their higher co-pays.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00006881?utm_source=OpenPR&utm_medium=Simran

Among developing countries such as India, where the paying capacity is relatively low, generic drugs for cancer treatment acts as a boon for both the manufacturers as well as patients due to its affordability and efficacy. For instance, in June 2016, Hetero launched a Biosimilar 'Bevacizumab' for the treatment of metastatic colorectal cancer under the brand name “Cizumab”. One of the most striking benefit of using generic drugs is the cost that is up to 85% less than that of the branded drugs.

Colorectal Cancer Market to 2027 - Global Analysis and Forecasts By Modality (Diagnosis Type, Therapy Type); End User (Hospitals, Diagnostic and Research Laboratories); and Geography

The global colorectal cancer market is expected to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027.

Driving factors of the colorectal cancer are increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover, growing pharmaceutical industry in emerging economies is likely to have a positive impact on the growth of the market in the coming years.

The colorectal cancer is found among the significant population in the North American regions. For instance, according to the Centers for Disease Control and Prevention (CDC) and American Cancer Society, an estimated 145,600 adults in the United States were diagnosed, and 51,020 deaths were reported with colorectal cancer in 2018.

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00006881?utm_source=OpenPR&utm_medium=Simran

Contact us –
Phone : +1-646-491-9876
Email Id : sales@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release At 4% of CAGR, Colorectal Cancer Market is Growing with $22,953.8 Million in 2027 - Clinical Genomics Technologies, EDP Biotech Corporation, Volitionrx Limited, Abbott Laboratories, Amgen, F. Hoffmann-La Roche here

News-ID: 1869441 • Views:

More Releases from The Insight Partners

Infantile Spasms Therapeutics Market Partnering Deals of Key Players 2024-2031
Infantile Spasms Therapeutics Market Partnering Deals of Key Players 2024-2031
The Infantile Spasms Therapeutics Market size (volume and value) and industry chain structure published by The Insight Partners through its high quality database which is a valuable source of guidance and direction for companies and individual interested in the industry. Major companies with their market volumes and revenues are covered for each of the regions (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America). Download Sample PDF
Sailcloth Market SWOT analysis by Size, Status and Forecast 2030
Sailcloth Market SWOT analysis by Size, Status and Forecast 2030
The latest market research released by The Insight Partners- "Growth Projections on Sailcloth Market - Statistics and Facts" is the one-stop solution for all Sailcloth market-related queries. Sailcloth market size is projected to grow from US$ 133.18 million in 2022 to US$ 171.69 million by 2030; it is anticipated to register a CAGR of 3.2% from 2022 to 2030. This report offers a thorough picture of those challenges to prepare businesses
Pigments Market Analysis by Industry Perspective, Comprehensive Analysis, Growth and Forecast 2021-2031
Pigments Market Analysis by Industry Perspective, Comprehensive Analysis, Growth …
The Pigments Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00003576/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • BASF SE • Cabot Corporation • Clariant • DIC CORPORATION • E. I. du Pont de Nemours and Company • Flint Group • Heubach GmbH • Huntsman International LLC • KRONOS Worldwide, Inc. • LANXESS The report scrutinizes different business approaches and frameworks that
Drug Delivery Technology Market Is Gaining Huge Growth In Upcoming Years
Drug Delivery Technology Market Is Gaining Huge Growth In Upcoming Years
Drug delivery in the systemic circulation is a very important part of medication and medical treatment. There are various drug delivery systems used to deliver therapeutic substances into the human body. Technological advancements make drug delivery very adjustable and convenient to the patients. Transdermal, oral, nasal, and parenteral are types of drug delivery systems. Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPRE00027304/?utm_source=OpenPR&utm_medium=10129 Drug Delivery Technology Market: Competitive Landscape

All 5 Releases


More Releases for Generic

Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs. The global generic drugs market is driven by the rise of
Generic Wellness Offers Special Discount on Generic Xenical for Fat Reduction !
This week a special offer is introduced by Generic Wellness for weight loss treatment with an oral drug called generic Xenical. The drug is an excellent weight loss treatment for all men and women above the age of 12. People who have taken this drug for weight loss have actually experienced the benefits like reduction of unwanted fat in the body. This is possible with generic Xenical because of the
Generic Drugs Market Trends 2025
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Generic Drugs Market - Global Competitive Analysis
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by